Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$184.17 USD
-0.31 (-0.17%)
Updated Sep 20, 2024 03:56 PM ET
After-Market: $184.28 +0.11 (0.06%) 5:22 PM ET
1-Strong Buy of 5 1
F Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
KRYS 184.17 -0.31(-0.17%)
Will KRYS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KRYS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for KRYS
Longboard Stock Soars on FDA Designations for Epilepsy Drug
J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC
KRYS: What are Zacks experts saying now?
Zacks Private Portfolio Services
VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
EWTX Stock Soars on Upbeat Efficacy Data From Cardiomyopathy Studies
Other News for KRYS
Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference
Redmile Group, LLC Expands Stake in Atara Biotherapeutics Inc
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Beam Therapeutics price target raised to $69 from $66 at Stifel
Krystal Biotech price target raised to $220 from $204 at Stifel